Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. An acknowledgement
3. The GLP panel
4. OECD
5. Countries adherent to OECD MAD decisions
6. The OECD MAD decision C(81)30 (final)
7. OECD decision-recommendation C(89)87(final) (1)
8. OECD decision-recommendation C(89)87(final) (2)
9. OECD council decision-recommendation: Annex I
10. OECD council decision-recommendation: Annex II
11. Annex III to council decision C(89)87(final)
12. Mutual acceptance of data
13. The mutual joint visit (MJV) pilot project (1)
14. The mutual joint visit (MJV) pilot project (2)
15. Parties involved in the MJV pilot project
16. MJV steering group
17. Working group on GLP
18. Outcome of the MJV report
19. MJV pilot project (1)
20. MJV pilot project (2)
21. The whole project
22. Programme of on-site evaluation visits (1)
23. Programme of on-site evaluation visits (2)
24. Pre-visit documentation review
25. On-site evaluation visit (1)
26. On-site evaluation visit (2)
27. Programme of on-site evaluation visits (3)
28. Progress of the on-site evaluation program
29. Concluding remarks

Topics Covered

• Countries with a GLP monitoring program (1989): the GLP panel
• OECD
• The OECD MAD decision C(81)30 (final)
• OECD council decision-recommendation C(89)87(final)
• Annex I, II and III
• Mutual acceptance of data
• Objective of the mutual joint visit (MJV) pilot project
• Working group on GLP
• MJV pilot project
• Programme of on-site evaluation visits

Links

Series:

• Good Laboratory Practice

Categories:

• Methods
• Pharmaceutical Sciences

Talk Citation

Helder, T. (2012, September 13). History and rationale for the development of an international evaluation programme [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 19, 2024, from https://hstalks.com/bs/2393/.
Export Citation (RIS)

Publication History

• Published on September 13, 2012

Financial Disclosures

• Mr. Theo Helder has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.